Wells Fargo upgrades Zimmer Biomet Holdings to Overweight from Equal-Weight, raises price target to $123
Wells Fargo upgraded Zimmer Biomet Holdings to Overweight, raising its price target to $123 from $113, suggesting 21.3% upside from the Nov 16 close of $101.41. Recent analyst price targets range from $101 to $140.

